Company Nanobac Pharmaceuticals, Incorporated Other OTC
Equities
NNBP
US63007M1027
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Therapeutic & Diagn
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -92.17% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Finland
96.9
%
| 0 | 9.2 % | 0 | 96.9 % | -17.94% |
United States
3.1
%
| 0 | 90.8 % | 0 | 3.1 % | -99.74% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 249,506,760 | 249,506,760 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Nanobac Pharmaceuticals, Inc.
5025 West Lemon Street
33609, Tampa
+
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.13% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |